Recent Finacing
Recent Raise
Tisento is a biopharma developing brain-penetrant sGC stimulators, advancing zagociguat (Phase 2a biomarker and safety data) into Phase 2b for MELAS after acquiring zagociguat and CY3018 from Cyclerion.
Focus Areas
Recent Investors
Valuation as of 07/31/2023
Total Raised
Funding round
Investors